Shanxi Zhendong Pharmaceutical
Launch date
Employees
Market cap
€421m
Enterprise valuation
€178m (Public information from Sep 2024)
Share price
CNY3.24 300158.SZ
Changzhi Shanxi (HQ)
Financials
Estimates*
| CNY | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | - | - | 4.4b | 4.8b | 5.1b | 3.7b | 3.6b |
| % growth | - | - | - | 10 % | 5 % | (27 %) | (3 %) |
| EBITDA | - | - | 367m | 535m | 3.3b | 82.3m | 102m |
| % EBITDA margin | - | - | 8 % | 11 % | 65 % | 2 % | 3 % |
| Profit | - | - | 143m | 262m | 2.6b | (51.3m) | (44.0m) |
| % profit margin | - | - | 3 % | 5 % | 51 % | (1 %) | (1 %) |
| EV / revenue | - | - | 1.0x | 1.1x | 0.6x | 1.3x | 1.3x |
| EV / EBITDA | - | - | 12.0x | 9.7x | 0.9x | 60.0x | 46.1x |
| R&D budget | - | - | 145m | 136m | 219m | 178m | 191m |
| R&D % of revenue | - | - | 3 % | 3 % | 4 % | 5 % | 5 % |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| Total Funding | - | ||
